Cronos Australia Limited is listed on the ASX (ASX:CAU).
The vision of Cronos Australia is to become a leading health and wellness company in the Asia Pacific region through the creation and distribution of premium medical and consumer cannabinoid products and services.
The Company’s largest shareholder is Cronos Group Inc. (NASDAQ:CRON; TSX:CRON).
Cronos Australia owns 75.5% of Cannadoc Health Pty Ltd, a medicinal cannabis clinic business that undertakes face-to-face and nationwide telehealth consultations with patients seeking access to medicinal cannabis.
Cronos Australia has established operations in Hong Kong and Japan for the development of ranges of cannabinoid brands and products and their distribution into global consumer markets.
The first two ranges of products are Bathing Shed, and FCTR.
KEY PEOPLE

Dr. Marcia A.M. Walker, Director
Dr. Marcia Walker was appointed Non-Executive Director of Cronos Australia on 16 December 2021. Marcia brings significant experience in Medical Governance and currently serves on the board of the New Zealand Medical Association, is a member of the General Practitioner Council of the NZMA, a member of the Medicines Classifications Committee for the Ministry of Health NZ and acts as a Medical Examiner for the Royal New Zealand College of General Practitioners. Previously, she acted as a Medical Advisor to the Rua BioScience (formerly Hikurangi Hemp Company) and Treasurer for the New Zealand Resident Doctors Association. Marcia received a Bachelor of Medicine and a Bachelor of Surgery / Chirurgery from the University of Auckland and is a fellow of the Royal New Zealand College of General Practitioners. She also acts as the Medical Director of The Cosmetic Clinic New Zealand.

Guy R. Headley, Chief Commercial Officer and Executive Director
Guy Headley was appointed Executive Director and Chief Commercial Officer of Cronos Australia on 16 December 2021. Guy has operated in the Australian Medical Cannabis space since 2016. He is a founding director of CDA Health Pty. Ltd. and has acted as a director of Burleigh Heads Cannabis Pty. Ltd. over the last five years. He brings a wealth of knowledge regarding medicinal cannabis sales, distribution and compliance in the heavily regulated industry. Prior to working in the cannabis space, Guy spent more than 15 years in the construction and development sector overseeing the procurement and management of multimillion dollar projects across New Zealand, Australia and the United Kingdom. Guy is also a founding Director of the Emerging Therapeutics Association of Australia.

Dr Benjamin D.N. Jansen, Chief Medical Officer and Executive Director
Dr. Ben Jansen was appointed Executive Director and Chief Medical Officer of Cronos Australia on 16 December 2021. As a founding Director of CDA Health Pty. Ltd. and Cannabis Doctors Australia Pty. Ltd., Ben has played a key role in advancing and advocating access and education for medicinal cannabis patients within Australia and New Zealand. Ben is arguably Australia’s most experienced medicinal cannabis clinician, having been directly involved with the treatment of thousands of patients. He is a Fellow of the Royal Australian and Royal New Zealand College of General Practitioners and a Fellow of the Royal New Zealand College of Urgent Care Physicians. Ben received a Bachelors degree of Medicine, a Bachelors degree of Surgery, a Bachelors degree of Human Biology, and a Post Graduate Diploma in Community Emergency Medicine from the University of Auckland. He also received a Post Graduate Diploma in Sports Medicine from the University of Otago in New Zealand.
RELATED STOCKHEAD STORIES
News
ASX Small Cap Lunch Wrap: Who’s in search of paradise this morning?
News
8 small caps that are leading the way as ASX quarterlies roll in
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
News
10 at 10: These ASX stocks are holding firm this morning
Health & Biotech
ASX pot stocks are getting high after TGA interim ruling
IPO Watch
IPO Watch: Emerald Clinics is the latest pot stock to wilt on its ASX debut
IPO Watch
IPO Watch: These are the top ASX debutantes of 2019
IPO Watch
IPO Watch: Pipeline stays healthy as three more companies list in November
Health & Biotech
Weed Week: Thought the Brits weren’t into cannabis? Think again
News
Lunchtime ASX small cap wrap: Who’s fallen out of the paddy wagon today?
Health & Biotech
It’s not that easy bein’ green: Aussie pot stocks start FY20 in a slump
IPO Watch
IPO Watch: Cronos Australia closes down 32pc on ASX debut
Health & Biotech